Latigo Biotherapeutics Inc., headquartered in Thousand Oaks, CA, is a privately held clinical-stage biotechnology company developing best-in-class non-opioid pain medicines that target the fundamental mechanism of pain transduction. The company’s proprietary, in-house technology generates novel drugs against targets validated by human genetics using the most advanced artificial intelligence, machine learning, structure-based, and knowledge-based design techniques to optimize potency and selectivity. The company is backed by top-tier investors, including Westlake Village BioPartners, 5AM Ventures, Foresite Capital, and Corner Ventures.
| Website | https://www.latigobio.com |
| Revenue | $8.8 million |
| Employees | 50 (39 on RocketReach) |
| Industry | Biotechnology Research |
| Keywords | Pain Management, Biotechnology, Non-Opioid Analgesics, Opioid Alternatives, Clinical Stage, Innovative Therapies, Drug Development, Pharmaceutical, Clinical Trials, Best In Class, Drug Discovery, Therapeutics, New Drug Applications, Pharmaceutical Research, Biopharma, Healthcare |
| Competitors | Amgen, Gilead Sciences, AbbVie, Vertex Pharmaceuticals, Illumina, Incyte, Biogen, Regeneron, Moderna Therapeutics, Receptos, a wholly-owned subsidiary of Celgene +42 more (view full list) |
Looking for a particular Latigo Biotherapeutics, Inc. employee's phone or email?
Latigo Biotherapeutics, Inc. Questions
The Latigo Biotherapeutics, Inc. annual revenue was $8.8 million in 2026.
Nima Farzan is the CEO of Latigo Biotherapeutics, Inc..
39 people are employed at Latigo Biotherapeutics, Inc..
Latigo Biotherapeutics, Inc. is based in Thousand Oaks, California.
Top Latigo Biotherapeutics, Inc. Employees
-
Nima Farzan
Chief Executive Officer at Latigo Biotherapeutics, Inc.
San Francisco, CA, US55 -
Bryan Moyer
Senior Vice President, Discovery at Latigo Biotherapeutics, Inc.
Thousand Oaks, CA, US34 -
Neil Singla
Chief Medical Officer at Latigo Biotherapeutics, Inc.
Pasadena, CA, US35+ -
Mike Kaufman
Vice President, Head of Chemistry at Latigo Biotherapeutics, Inc.
Thousand Oaks, CA, US23 -
5+5+
-
Sabrina Nieder
Vice President, Corporate Controller at Latigo Biotherapeutics, Inc.
San Francisco, CA, US41 -
Holly Carlisle
VP, Translational Science at Latigo Biotherapeutics, Inc.
Thousand Oaks, CA, US15+ -
25
-
1
-
35+
Related Companies
